Total Payments
$13,455
2024 Payments
$2,440
Companies
48
Transactions
545
Medicare Patients
6,662
Medicare Billing
$777,622
Payment Breakdown by Category
Food & Beverage$13,241 (98.4%)
Education$214.54 (1.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,241 | 540 | 98.4% |
| Education | $214.54 | 5 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,285 | 68 | $0 (2024) |
| Abbott Laboratories | $1,223 | 29 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,037 | 31 | $0 (2024) |
| PFIZER INC. | $1,016 | 73 | $0 (2024) |
| Medtronic, Inc. | $853.27 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $761.07 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $640.32 | 32 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $566.70 | 28 | $0 (2024) |
| ShockWave Medical, Inc | $560.73 | 4 | $0 (2024) |
| ABIOMED | $540.94 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,440 | 99 | Boehringer Ingelheim Pharmaceuticals, Inc. ($287.85) |
| 2023 | $2,591 | 104 | Novartis Pharmaceuticals Corporation ($342.55) |
| 2022 | $3,340 | 108 | Abbott Laboratories ($412.70) |
| 2021 | $1,570 | 58 | BIOTRONIK INC. ($348.12) |
| 2020 | $734.60 | 36 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($228.66) |
| 2019 | $1,399 | 73 | Abbott Laboratories ($190.42) |
| 2018 | $917.27 | 41 | Medtronic Vascular, Inc. ($212.54) |
| 2017 | $464.62 | 26 | Gilead Sciences Inc ($182.80) |
All Payment Transactions
545 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Heart Failure | ||||||
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: DIABETES | ||||||
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Heart Failure | ||||||
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Heart Failure | ||||||
| 12/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.71 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/09/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DEVICES | ||||||
| 12/06/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $21.12 | General |
| Category: Medical Device | ||||||
| 12/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $222.93 | General |
| Category: Lithoplasty | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: DIABETES | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.55 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | CARDIVA MEDICAL, INC. | SAVVYWIRE (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: DEVICES | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,124 | 4,555 | $771,653 | $257,967 |
| 2022 | 27 | 1,893 | 3,414 | $617,984 | $205,861 |
| 2021 | 26 | 1,654 | 2,588 | $515,373 | $202,304 |
| 2020 | 20 | 991 | 1,365 | $254,919 | $111,490 |
Total Patients
6,662
Total Services
11,922
Medicare Billing
$777,622
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 93 | 945 | $89,775 | $31,652 | 35.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 101 | 633 | $94,950 | $29,826 | 31.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 97 | 662 | $76,130 | $27,345 | 35.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 110 | 252 | $63,000 | $25,529 | 40.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 107 | 109 | $76,300 | $18,159 | 23.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 40 | 40 | $44,000 | $16,584 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 199 | $22,288 | $14,927 | 67.0% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 15 | 15 | $27,759 | $11,916 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 82 | $12,956 | $9,044 | 69.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 154 | 157 | $37,680 | $8,584 | 22.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 62 | $17,050 | $8,540 | 50.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 177 | 207 | $19,665 | $7,956 | 40.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 39 | 156 | $16,380 | $6,724 | 41.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 96 | $11,040 | $6,284 | 56.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 42 | 81 | $64,800 | $5,930 | 9.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $14,700 | $4,134 | 28.1% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 18 | 18 | $14,400 | $3,876 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $5,450 | $3,806 | 69.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $10,125 | $3,449 | 34.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 50 | 51 | $13,515 | $3,216 | 23.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 229 | 266 | $13,300 | $2,962 | 22.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $6,075 | $2,615 | 43.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 301 | 313 | $4,915 | $1,998 | 40.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 11 | 11 | $5,500 | $998.47 | 18.2% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 18 | 18 | $3,510 | $801.15 | 22.8% |
About Dr. Tae Yang, M.D
Dr. Tae Yang, M.D is a Interventional Cardiology healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821262072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tae Yang, M.D has received a total of $13,455 in payments from pharmaceutical and medical device companies, with $2,440 received in 2024. These payments were reported across 545 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($13,241).
As a Medicare-enrolled provider, Yang has provided services to 6,662 Medicare beneficiaries, totaling 11,922 services with total Medicare billing of $777,622. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Fountain Valley, CA
- Active Since 04/18/2008
- Last Updated 07/23/2018
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1821262072
Products in Payments
- ELIQUIS (Drug) $1,051
- LifeVest (Device) $1,037
- ENTRESTO (Drug) $848.68
- XARELTO (Drug) $640.32
- JARDIANCE (Drug) $627.62
- Impella (Device) $540.94
- FLOWTRIEVER CATHETER, S (Device) $463.37
- LEQVIO (Drug) $436.78
- MULTAQ (Drug) $345.41
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $321.33
- MITRACLIP (Device) $311.71
- LINQ II (Device) $266.34
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $239.40
- FARXIGA (Drug) $210.10
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $200.48
- Orsiro (Device) $194.35
- Repatha (Biological) $191.61
- Amplatzer Cardiac Plug (Device) $190.42
- Confirm Rx (Device) $185.23
- Arcalyst (Drug) $175.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.